3 ms·
I think the research you linked is for T2D (non-insulin dependent). It's interesting the research into Verapamil apparently is for both T1 and T2, since my unde
by zaroth 12y ago
I think the research you linked is for T2D (non-insulin dependent). It's interesting the research into Verapamil apparently is for both T1 and T2, since my understanding was the mechanism of the diseases were entirely different.
With T1D your body stops producing insulin due to beta cell death caused by an autoimmune disorder, so you need to constantly monitor your blood glucose level and carb intake in order to dose yourself with the right amount of insulin multiple times per day, or you go into hypo/hyperglycemia.
I'm much less familiar with T2D, but I thought the body produces more and more insulin but becomes resistant and the insulin fails to adequately control blood glucose level. Beta cell death in T2D is then a follow-on confounding factor due to the persistently high glucose levels.
Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities: http://www.ncbi.nlm.nih.gov/pubmed/16306347 http://www.ncbi.nlm.nih.gov/pubmed/16306347
- coldpie 12y agoYes. It is always frustrating to have to dig through paragraphs of text to find out which of the two, basically unrelated diseases the article is talking about. I really wish they had different names.
- hockeybias 12y agoAs somebody who got type 1 at age 41, I could not agree more.